Fulgent Genetics, Inc. FLGT Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.
The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fulgent Genetics, Inc.'s additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Fulgent Genetics, Inc.'s additional paid-in capital?
- Fulgent Genetics, Inc. (FLGT) reported additional paid-in capital of $540.14M in Q1 2026.
- How has Fulgent Genetics, Inc.'s additional paid-in capital changed year-over-year?
- Fulgent Genetics, Inc.'s additional paid-in capital decreased by 0.7% year-over-year, from $543.9M to $540.14M.
- What is the long-term trend for Fulgent Genetics, Inc.'s additional paid-in capital?
- Over 5 years (2020 to 2025), Fulgent Genetics, Inc.'s additional paid-in capital has grown at a 6.6% compound annual growth rate (CAGR), from $418.07M to $574.52M.
- What does additional paid-in capital mean?
- Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.